Conservest Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $392K | Buy |
1,083
+33
| +3% | +$11.3K | 0.03% | 96 |
|
|
2026
Q1 | $369K | Buy |
1,050
+18
| +2% | +$6.42K | 0.03% | 91 |
|
|
2025
Q4 | $338K | Sell |
1,032
-7
| -0.7% | -$2.22K | 0.03% | 96 |
|
|
2025
Q3 | $293K | Sell |
1,039
-4
| -0.4% | -$1.16K | 0.03% | 101 |
|
|
2025
Q2 | $291K | Buy |
1,043
+17
| +2% | +$4.82K | 0.03% | 102 |
|
|
2025
Q1 | $320K | Hold |
1,026
| – | – | 0.03% | 86 |
|
|
2024
Q4 | $267K | Buy |
1,026
+175
| +21% | +$51.9K | 0.03% | 95 |
|
|
2024
Q3 | $242K | Hold |
851
| – | – | 0.02% | 97 |
|
|
2024
Q2 | $242K | Hold |
851
| – | – | 0.03% | 96 |
|
|
2024
Q1 | $242K | Hold |
851
| – | – | 0.02% | 97 |
|
|
2023
Q4 | $245K | Hold |
851
| – | – | 0.03% | 93 |
|
|
2023
Q3 | $229K | Buy |
+851
| New | +$212K | 0.03% | 91 |
|
|
2023
Q2 | – | Sell |
-851
| Closed | -$206K | – | 103 |
|
|
2023
Q1 | $206K | Hold |
851
| – | – | 0.02% | 93 |
|
|
2022
Q4 | $224K | Buy |
+851
| New | +$228K | 0.03% | 83 |
|
|
2022
Q3 | – | Sell |
-851
| Closed | -$207K | – | 91 |
|
|
2022
Q2 | $207K | Hold |
851
| – | – | 0.03% | 85 |
|
|
2022
Q1 | $206K | Buy |
+851
| New | +$196K | 0.02% | 82 |
|
|
2021
Q3 | – | Sell |
-851
| Closed | -$207K | – | 82 |
|
|
2021
Q2 | $207K | Hold |
851
| – | – | 0.02% | 79 |
|
|
2021
Q1 | $212K | Buy |
+851
| New | +$203K | 0.02% | 76 |
|
|
2020
Q4 | – | Sell |
-851
| Closed | -$216K | – | 77 |
|
|
2020
Q3 | $216K | Hold |
851
| – | – | 0.03% | 70 |
|
|
2020
Q2 | $201K | Buy |
+851
| New | +$194K | 0.03% | 69 |
|
|
2020
Q1 | – | Sell |
-851
| Closed | -$205K | – | 70 |
|
|
2019
Q4 | $205K | Buy |
+851
| New | +$188K | 0.03% | 78 |
|
|
2018
Q4 | – | Sell |
-1,828
| Closed | -$379K | – | 81 |
|
|
2018
Q3 | $379K | Hold |
1,828
| – | – | 0.06% | 64 |
|
|
2018
Q2 | $337K | Sell |
1,828
-1,325
| -42% | -$234K | 0.05% | 64 |
|
|
2018
Q1 | $537K | Hold |
3,153
| – | – | 0.12% | 47 |
|
|
2017
Q4 | $548K | Buy |
3,153
+12
| +0.4% | +$2.12K | 0.11% | 47 |
|
|
2017
Q3 | $586K | Buy |
3,141
+11
| +0.4% | +$1.95K | 0.09% | 55 |
|
|
2017
Q2 | $539K | Buy |
3,130
+13
| +0.4% | +$2.11K | 0.11% | 44 |
|
|
2017
Q1 | $511K | Buy |
+3,117
| New | +$518K | 0.11% | 46 |
|
Other funds holding AMGN
Conservest Capital Advisors's AMGN Position: Q2 2026 in Review
Conservest Capital Advisors increased its Amgen (AMGN) stake by 3.1% in Q2 2026, buying an estimated $11.3K and bringing the position to 1,083 shares worth $392K. The position accounts for 0.03% of the portfolio, ranked #96.
Conservest Capital Advisors first reported a position in AMGN in Q1 2017 and has held it in 28 quarters since. The position peaked at $586K in Q3 2017. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Conservest Capital Advisors held 1,083 shares of Amgen worth $392K as of Q2 2026.
- Conservest Capital Advisors bought 33 Amgen shares in Q2 2026, an estimated $11.3K.
- Amgen made up 0.03% of Conservest Capital Advisors's portfolio in Q2 2026, its #96 holding.
- Conservest Capital Advisors first reported a position in Amgen in Q1 2017 and has held it in 28 quarters since.
- Conservest Capital Advisors's Amgen position peaked at $586K in Q3 2017.
- 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Conservest Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.